Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
6th grade Avg
|
|
New words:
AB, Additionally, agreed, anniversary, applied, asset, asthma, ATD, biotechnology, buy, cathepsin, commenced, commencement, efficacy, escalating, experience, fact, fixed, founding, greater, inflammatory, inhaled, inhibit, intended, Inventory, investor, kind, knowledgeable, mutually, newly, occasionally, owner, paid, pharmacogenomic, point, PPD, ppgx, premium, primary, Raw, recently, relevant, resale, Rorer, royalty, running, safety, shareholder, sophisticated, spin, sponsoring, supply, thereof, ulcerative, undergoing, view, virtue, volatility, work, worldwide
Removed:
Abbott, absolute, achieved, AG, allocation, Amgen, amortized, assumed, Bayer, Beecham, begun, BI, bipolar, BMS, Board, broad, California, cardiovascular, central, characterize, charge, charged, collection, combination, combined, committed, compliance, computation, computed, consideration, consummated, converted, discover, discussion, disorder, display, effective, ending, established, Eurodollar, extend, forma, functional, geographic, Glaxo, higher, immaterial, infection, inhibitor, initial, initiated, integration, interim, invested, involved, issuing, jointly, Jolla, june, La, leader, Merck, monthly, NemaPharm, Nonrecurring, obtained, occurred, operation, organic, original, patient, PD, PNU, positive, presently, pro, Protease, rate, receipt, reflected, reimbursement, relinquish, renew, reorganization, replacing, reporting, respiratory, SB, schizophrenia, scope, selected, september, shipment, Silicon, SmithKline, Squibb, statement, straight, Sumitomo, summary, superseded, synthetic, table, transaction, tryptase, unable, Valley, variety, warrant, wholly
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.97 Employment Agreement
- 10.98 Series a Preferred Stock Purchase Agreement
- 10.99 Third Amendment to Expansion Lease
- 10.100 Fourth Amendment to Expansion Lease
- 10.101 First Amendment to the Research Agreement
- 10.102 Seventh Amendment to the Lease Agreement
- 10.103 Eighth Amendment to the Lease Agreement
- 10.104 Ninth Amendment to the Lease Agreement
- 10.105 Terminantion of Collaborative Research Agreement
- 10.106 Termination Agreement
- 27 Financial Data Schedule
Axys Pharmaceuticals similar filings
External links